Crossject SA, 2026-06-05
An SEC Form D private-offering notice from Dijon, a $10,259,936 filer-stated offering target in Biotech. Filed 2026-06-05. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
French specialty pharmaceutical company developing ZENEO, a needle free auto injector for rapid delivery of emergency medications such as epinephrine and anti epileptic rescue therapy.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Los Angeles Project Inc, 2026-06-05, $1.5M, Austin, TX
- Spine BioPharma, Inc., 2026-06-05, $8.5M, New York, NY
- Antlia Bioscience, Inc., 2026-06-05, $20M, Encinitas, CA
- Illuminare Biotechnologies Inc, 2026-06-04, $4M, Brooklyn, NY
- Senti Biosciences Holdings, Inc., 2026-06-04, $40M, South San Francisco, CA
- Ardego Therapeutics, Inc., 2026-06-03, $3M, Gaithersburg, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.